SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001123292-19-000910
Filing Date
2019-06-26
Accepted
2019-06-26 16:18:04
Documents
2
Period of Report
2019-06-24

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 1650
2 POWER OF ATTORNEY collier.htm EX-24 8846
  Complete submission text file 0001123292-19-000910.txt   12040
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Issuer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ARBUTUS BIOPHARMA CORPORATION 701 VETERANS CIRCLE WARMINSTER PA 18974
Business Address
Collier William H. (Reporting) CIK: 0001780495 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34949 | Film No.: 19921805